Release Date: 06/02/15 10:17 Summary: Appendix 3X - Initial Directors Interest Notice- Nancy Milne Price Sensitive: No Download Document 260.08KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status